- November 29, 2022 06:36 PM AEDT
BRIEF-Althea Group Holdings Says Well Positioned To Achieve Operating Profitability In Q3 Fy23
- November 29, 2022 05:40 PM AEDT | Reuters
Nov 29 (Reuters) - Althea Group Holdings Ltd: * CO WELL POSITIONED TO ACHIEVE ITS GOAL OF REACHING CASH FLOW BREAK EVEN AND OPERATING PROFITABILITY IN Q3 FY23 Source text for Eikon: Further companyRead More...
Why are Microba Life Sciences’ (ASX:MAP) shares up 68%?
- November 29, 2022 02:37 PM AEDT | Sonal Goyal
Microba Life Sciences’ share price shot up by 68% on Tuesday after the company shared that Sonic has bought 19.99% stake in the company.Read More...
BRIEF-Microba Says Sonic Acquires 19.9% Stake In Co And Enters Partnership
- November 29, 2022 12:40 PM AEDT | Reuters
Nov 29 (Reuters) - Microba Pty Ltd: * SONIC ACQUIRES 19.9% MICROBA STAKE AND ENTERS PARTNERSHIP * SONIC HEALTHCARE HAS AGREED TO INVEST A$17.8 MILLION TO ACQUIRE 19.99% SHAREHOLDING IN MICROBA * SONICRead More...
BRIEF-Wellnex Life Says On Track To Meet Revenue Guidance For Current FY
- November 29, 2022 12:39 PM AEDT | Reuters
Nov 29 (Reuters) - Wellnex Life Ltd: * ON TRACK TO MEET REVENUE GUIDANCE FOR CURRENT FY Source text for Eikon: Further company coverage:Read More...
BRIEF-Immutep Says Enters 2nd Collaboration With Pfizer And Merck KGaA
- November 29, 2022 12:33 PM AEDT | Reuters
Nov 29 (Reuters) - Immutep Ltd: * IMMUTEP ENTERS 2ND COLLABORATION WITH PFIZER AND MERCK KGAA * SIGNED CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT FOR NEW PHASE I CLINICAL STUDY IN PATIENTS WITHRead More...
BRIEF-Incannex Healthcare Says Engages Eurofins To Manufacture Renecann Therapeutic
- November 29, 2022 12:33 PM AEDT | Reuters
Nov 29 (Reuters) - Incannex Healthcare Ltd: * ENGAGES EUROFINS TO MANUFACTURE RENECANN THERAPEUTIC TOPICAL APPLICATION FOR IMMUNE DISORDERED SKIN DISEASES Source text for Eikon: Further companyRead More...
BRIEF-Pyc Therapeutics Says Has Increased Its Shareholding In Vision Pharma
- November 29, 2022 12:32 PM AEDT | Reuters
Nov 29 (Reuters) - PYC Therapeutics Ltd: * HAS INCREASED ITS SHAREHOLDING IN VISION PHARMA TO 95.2% * INCREASED SHAREHOLDING VIA A A$10 MILLION RE-CAPITALISATION Source text for Eikon: Further companyRead More...
BRIEF-4Dmedical Receives A$9.4 Million Milestone Payment From Medical Research Future Fund
- November 29, 2022 12:29 PM AEDT | Reuters
Nov 29 (Reuters) - 4DMedical Ltd: * 4DMEDICAL RECEIVES A$9.4 MILLION MILESTONE PAYMENT FROM MEDICAL RESEARCH FUTURE FUND Source text for Eikon: Further company coverage: (Reporting by Poonam Behura)Read More...
BRIEF-Impedimed Announces Appointment Of Richard Valencia As CEO
- November 29, 2022 12:00 PM AEDT | Reuters
Nov 29 (Reuters) - ImpediMed Ltd: * ANNOUNCE APPOINTMENT OF RICHARD VALENCIA AS MANAGING DIRECTOR AND CHIEF EXECUTIVE OFFICER Source text for Eikon: Further company coverage:Read More...
Frequently Asked Questions
Are healthcare stocks a good investment?
Given the fact that healthcare is a necessity, investing in healthcare stocks can be rewarding. However, to make good returns from these stocks, an investor should have sound knowledge about the sector and should be aware of the latest trends in the sector.
What should I look before invest in healthcare stocks?
The standard checklist that one would run to find a good stock, holds true for screening healthcare stocks too. However, there are few aspects that are important to be considered for healthcare stocks. Well established pharmaceutical stocks with a good history of drug discovery and effective treatments typically have some sort of moat around them, thanks to their scale and financial wherewithal. However, new, and small companies with unique innovations or a strong product pipeline are also worth investigating, as they have a longer runway. Healthcare companies are able to pass on inflation-led input cost pressure, since people usually do not cut back on their healthcare expenses even during an inflationary environment. Companies that are able to maintain good profit margin are seen commanding valuation premiums in the market. Investors can also look for healthcare companies with strong patent portfolio, as patents can provide good price and competition protection for longer periods. Finally, before finalising any share, some of the fundamentals such as return on equity, revenue growth, net margin growth, management capabilities in terms of capital allocation, dividend pay-out should be considered.